Divided Panel Upholds Patent Term Adjustment In Defeat For Appellant
WASHINGTON, D.C. — A decision by a Virginia federal judge to sustain the U.S. Patent and Trademark Office (PTO)’s calculation of a term adjustment for an immunosuppression therapy drug patent was...To view the full article, register now.
Already a subscriber? Click here to view full article